Michael R Dougherty's Net Worth

$2.32 Million

Estimate Recalculated Apr 1, 2024 06:26PM EST

Who is Michael R Dougherty?

Michael R Dougherty has an estimated net worth of $2.32 Million. This is based on reported shares across multiple companies, which include CEMPRA, INC., MARINUS PHARMACEUTICALS INC, Aviragen Therapeutics, Inc., Foundation Medicine, Inc., TREVENA INC, IDERA PHARMACEUTICALS, INC., VIROPHARMA INC, Celator Pharmaceuticals Inc, ADOLOR CORP, and GENAERA CORP.

SEC CIK

Michael R Dougherty's CIK is 0001033516

Past Insider Trading and Trends

2011 was Michael R Dougherty's most active year for acquiring shares with 13 total transactions. Michael R Dougherty's most active month to acquire stocks was the month of November. 2011 was Michael R Dougherty's most active year for disposing of shares, totalling 11 transactions. Michael R Dougherty's most active month to dispose stocks was the month of November. 2011 saw Michael R Dougherty paying a total of $1,624,800.00 for 762,000 shares, this is the most they've acquired in one year. In 2018 Michael R Dougherty cashed out on 24,789 shares for a total of $3,396,093.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CEMPRA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 1
Form 4
∞
2K
$18.45
$36,896.00
2K
Oct 26
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found

MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $9.935

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+489.32%
2.75K
—
—
3.31K
Feb 4
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
—
—
0
Dec 6
Form 3
—
0
—
—
0
No matching records found

Aviragen Therapeutics, Inc. (VXRT) Snapshot price: $1.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
Aug 11
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 1
Form 3
—
0
—
—
0
No matching records found

Foundation Medicine, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-24.79K
$137.00
-$3,396,093.00
0
Jul 31
Form 4
+30.45%
5.79K
$40.05
$231,729.30
24.79K
Jun 20
Form 4
∞
19K
$23.55
$447,520.65
19K
Oct 26
Form 3
—
0
—
—
0
No matching records found

TREVENA INC (TRVN) Snapshot price: $0.577

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 20
Form 4
∞
7K
$4.00
$28,000.00
7K
Dec 10
Form 4
—
0
—
—
0
May 14
Form 3
—
0
—
—
0
No matching records found